Susana Ben-Neriah
Overview
Explore the profile of Susana Ben-Neriah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
4165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delaidelli A, Burwag F, Ben-Neriah S, Suk Y, Shyp T, Kosteniuk S, et al.
Neuro Oncol
. 2025 Mar;
PMID: 40040502
Background: While international consensus and the 2021 WHO classification recognize multiple molecular medulloblastoma subgroups, these are difficult to identify in clinical practice utilizing routine approaches. As a result, biology-driven risk...
2.
Alduaij W, Jiang A, Villa D, Collinge B, Collinge B, Ben-Neriah S, et al.
Blood
. 2024 Oct;
145(6):590-596.
PMID: 39441916
High-grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2), or "double-hit lymphoma," has been associated with a high risk of central nervous system (CNS) relapse. However, historic estimates are impacted...
3.
Kuruvilla J, Rushton C, Villa D, Aslam M, Prica A, Abdel Samad N, et al.
Br J Haematol
. 2024 Sep;
205(5):2067-2071.
PMID: 39267295
In the LY.17 randomized phase II clinical trial, adults with relapsed and refractory diffuse large B-cell lymphoma treated with ibrutinib-R-GDP (IR-GDP) for up to three cycles had more documented bacterial...
4.
Collinge B, Ben-Neriah S, Hilton L, Alduaij W, Tucker T, Slack G, et al.
Blood
. 2024 Aug;
144(15):1611-1616.
PMID: 39133931
Fluorescence in situ hybridization (FISH) using break-apart probes is recommended for identifying high-grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2). Unbalanced MYC break-apart patterns, in which the red or...
5.
Shelton V, Detroja R, Liu T, Isaev K, Silva A, Passerini V, et al.
Blood Cancer J
. 2024 Aug;
14(1):128.
PMID: 39112453
Follicular lymphoma (FL) exhibits considerable variability in biological features and clinical trajectories across patients. To dissect the diversity of FL, we utilized a Bernoulli mixture model to identify genetic subtypes...
6.
Hilton L, Collinge B, Ben-Neriah S, Alduaij W, Shaalan H, Weng A, et al.
Blood
. 2024 May;
144(5):525-540.
PMID: 38701426
Rearrangements that place the oncogenes MYC, BCL2, or BCL6 adjacent to superenhancers are common in mature B-cell lymphomas. Lymphomas with diffuse large B-cell lymphoma (DLBCL) or high-grade morphology with both...
7.
Li M, Chong L, Duns G, Lytle A, Woolcock B, Jiang A, et al.
Proc Natl Acad Sci U S A
. 2024 Apr;
121(18):e2320421121.
PMID: 38662551
Here, we report recurrent focal deletions of the chr14q32.31-32 locus, including , a negative regulator of NF-κB signaling, in de novo diffuse large B cell lymphoma (DLBCL) (24/324 cases). Integrative...
8.
Grants J, May C, Bridgers J, Huang S, Gillis S, Meissner B, et al.
Clin Chem
. 2024 Jan;
70(1):273-284.
PMID: 38175592
Background: Somatic hypermutation (SHM) status of the immunoglobulin heavy variable (IGHV) gene plays a crucial role in determining the prognosis and treatment of patients with chronic lymphocytic leukemia (CLL). A...
9.
Aoki T, Jiang A, Xu A, Yin Y, Gamboa A, Milne K, et al.
J Clin Oncol
. 2023 Dec;
42(9):1077-1087.
PMID: 38113419
Purpose: About a third of patients with relapsed or refractory classic Hodgkin lymphoma (r/r CHL) succumb to their disease after high-dose chemotherapy followed by autologous stem-cell transplantation (HDC/ASCT). Here, we...
10.
Hilton L, Ngu H, Collinge B, Dreval K, Ben-Neriah S, Rushton C, et al.
J Clin Oncol
. 2023 Jun;
41(25):4164-4177.
PMID: 37319384
Purpose: Diffuse large B-cell lymphoma (DLBCL) is cured in more than 60% of patients, but outcomes remain poor for patients experiencing disease progression or relapse (refractory or relapsed DLBCL [rrDLBCL]),...